Cargando…

Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer

Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and predictive value. This involves the discovery process from assay development, image analysis, and data mining to the final interpretation and valida...

Descripción completa

Detalles Bibliográficos
Autores principales: Harder, Nathalie, Athelogou, Maria, Hessel, Harald, Brieu, Nicolas, Yigitsoy, Mehmet, Zimmermann, Johannes, Baatz, Martin, Buchner, Alexander, Stief, Christian G., Kirchner, Thomas, Binnig, Gerd, Schmidt, Günter, Huss, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849604/
https://www.ncbi.nlm.nih.gov/pubmed/29535336
http://dx.doi.org/10.1038/s41598-018-22564-7
_version_ 1783306065455087616
author Harder, Nathalie
Athelogou, Maria
Hessel, Harald
Brieu, Nicolas
Yigitsoy, Mehmet
Zimmermann, Johannes
Baatz, Martin
Buchner, Alexander
Stief, Christian G.
Kirchner, Thomas
Binnig, Gerd
Schmidt, Günter
Huss, Ralf
author_facet Harder, Nathalie
Athelogou, Maria
Hessel, Harald
Brieu, Nicolas
Yigitsoy, Mehmet
Zimmermann, Johannes
Baatz, Martin
Buchner, Alexander
Stief, Christian G.
Kirchner, Thomas
Binnig, Gerd
Schmidt, Günter
Huss, Ralf
author_sort Harder, Nathalie
collection PubMed
description Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and predictive value. This involves the discovery process from assay development, image analysis, and data mining to the final interpretation and validation of the findings. Importantly, this process is not linear but allows backward steps and optimization loops over multiple sub-processes. We provide a detailed description of the Tissue Phenomics methodology while exemplifying each step on the application of prostate cancer recurrence prediction. In particular, we automatically identified tissue-based biomarkers having significant prognostic value for low- and intermediate-risk prostate cancer patients (Gleason scores 6–7b) after radical prostatectomy. We found that promising phenes were related to CD8(+) and CD68(+) cells in the microenvironment of cancerous glands in combination with the local micro-vascularization. Recurrence prediction based on the selected phenes yielded accuracies up to 83% thereby clearly outperforming prediction based on the Gleason score. Moreover, we compared different machine learning algorithms to combine the most relevant phenes resulting in increased accuracies of 88% for tumor progression prediction. These findings will be of potential use for future prognostic tests for prostate cancer patients and provide a proof-of-principle of the Tissue Phenomics approach.
format Online
Article
Text
id pubmed-5849604
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58496042018-03-21 Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer Harder, Nathalie Athelogou, Maria Hessel, Harald Brieu, Nicolas Yigitsoy, Mehmet Zimmermann, Johannes Baatz, Martin Buchner, Alexander Stief, Christian G. Kirchner, Thomas Binnig, Gerd Schmidt, Günter Huss, Ralf Sci Rep Article Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and predictive value. This involves the discovery process from assay development, image analysis, and data mining to the final interpretation and validation of the findings. Importantly, this process is not linear but allows backward steps and optimization loops over multiple sub-processes. We provide a detailed description of the Tissue Phenomics methodology while exemplifying each step on the application of prostate cancer recurrence prediction. In particular, we automatically identified tissue-based biomarkers having significant prognostic value for low- and intermediate-risk prostate cancer patients (Gleason scores 6–7b) after radical prostatectomy. We found that promising phenes were related to CD8(+) and CD68(+) cells in the microenvironment of cancerous glands in combination with the local micro-vascularization. Recurrence prediction based on the selected phenes yielded accuracies up to 83% thereby clearly outperforming prediction based on the Gleason score. Moreover, we compared different machine learning algorithms to combine the most relevant phenes resulting in increased accuracies of 88% for tumor progression prediction. These findings will be of potential use for future prognostic tests for prostate cancer patients and provide a proof-of-principle of the Tissue Phenomics approach. Nature Publishing Group UK 2018-03-13 /pmc/articles/PMC5849604/ /pubmed/29535336 http://dx.doi.org/10.1038/s41598-018-22564-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Harder, Nathalie
Athelogou, Maria
Hessel, Harald
Brieu, Nicolas
Yigitsoy, Mehmet
Zimmermann, Johannes
Baatz, Martin
Buchner, Alexander
Stief, Christian G.
Kirchner, Thomas
Binnig, Gerd
Schmidt, Günter
Huss, Ralf
Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
title Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
title_full Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
title_fullStr Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
title_full_unstemmed Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
title_short Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
title_sort tissue phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849604/
https://www.ncbi.nlm.nih.gov/pubmed/29535336
http://dx.doi.org/10.1038/s41598-018-22564-7
work_keys_str_mv AT hardernathalie tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT athelogoumaria tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT hesselharald tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT brieunicolas tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT yigitsoymehmet tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT zimmermannjohannes tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT baatzmartin tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT buchneralexander tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT stiefchristiang tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT kirchnerthomas tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT binniggerd tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT schmidtgunter tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer
AT hussralf tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer